Neuroscience7 hours ago
Newleos Therapeutics Debuts with $93.5 Million Oversubscribed Series A Financing to Transform the Treatment of Neuropsychiatric Disorders through the Advancement of Novel Medicines
**Neuropsychiatric Breakthrough: Newleos Raises $93.5M for Revolutionary Mental Health Treatments** What’s Happening? Newleos Therapeutics, a neuroscience startup, has secured a staggering $93.5 million in Series A...
